Director/Sr. Director, Value & Health Economics

About BridgeBio

BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 20 drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs.

Our focus on scientific excellence and rapid execution aim to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zurich, Switzerland, and are expanding across Europe.

To learn more about our story and company culture, visit us at https://bridgebio.com

Who You Are

BridgeBio is looking for a Director, Value & Health Economics, to join our strong and growing team.  This position will report to the Head of Global Value & Health Economics and will support payer team by training on HEOR related tools and with HEOR related payer interaction.  Also, contributes to the conception and execution of innovative Market Access strategies to ensure patients access for all BridgeBio affiliate therapies and evolving product pipeline portfolio, providing insights to clinical trial development, clinical outcome assessments, and insights into competitive assessment. 

The ideal candidate should be prepared to work in a fast-paced environment and must be able to collaborate with external stakeholders and cross-functionally with Market Access, Commercial Operations, Marketing, Clinical Development, Regulatory Affairs and Strategic Planning. Effective collaboration and communication with external customers such as health care professionals and payers including presenting and participating in HTA appraisal committee &/or reimbursement meetings is also critical.

Responsibilities

• Assess HEOR needs related to specific diseases and pipeline assets and develop and execute programs of research aimed at preparing the necessary data package for products in development
• Collaborate cross-functionally with internal stakeholders including clinical development teams, medical affairs, market access and marketing to ensure relevant health economics measures are integrated into clinical studies and commercialization plans
• Interacts effectively with patient groups, clinical experts, and payers to understand the burden of diseases that are the target of BridegBio products
• Develop and validate new Patient Reported Outcomes measures, as appropriate, for inclusion across clinical trials, registries, and prospective real-world studies for BridgeBio affiliates where appropriate
• Lead the development of appropriate data dissemination plans and communicate evidence generated via publications, conference presentations, and other appropriate channels
• Possess extensive knowledge of health economic model design and analysis and be able to manage development in order to demonstrate complex value data in a straightforward and understandable manner to internal stakeholders, external KOLs, payers and HTA agencies
• Stay up to date with advancements in health economics methodologies and best practices

No matter your role at BridgeBio, successful team members are:

• Patient Champions, who put patients first and uphold strict ethical standards
• Entrepreneurial Operators, who drive toward practical solutions and have an ownership mindset
• Truth Seekers, who are detailed, rational, and humble problem solvers
• Individuals Who Inspire Excellence in themselves and those around them
• High-quality executors, who execute against goals and milestones with quality, precision, and speed

Education, Experience & Skills Requirements

• Master’s degree in health economics or related discipline
• 10 years of relevant experience in health economics and outcomes research
• Experience of Rare Diseases and HEOR early stage development activities and strategy
• Launch experience in a pharmaceutical company
• Proven track record of evidence synthesis (systematic literature review, indirect comparisons, etc.)
• Proven track record of developing economic models (cost-effectiveness, budget impact)
• Strong understanding of payer and HTA needs, and expertise in developing and delivering high quality submissions
• Domestic and international travel required, expected to be 10-20% of the time and as needed

What We Offer

• Patient Days, where we are fortunate to hear directly from individuals living with the conditions we are seeking to impact throughout the year and learn how we can improve our efforts
• A culture inspired by our values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak
• An unyielding commitment to always putting patients first. Learn more about how we do this here
• A de-centralized model that enables our program teams to focus on advancing science and helping patients. Our affiliate structure is designed to eliminate bureaucracy and put decision-making power in the hands of those closest to the science
• A place where you own the vision – both for your program and your own career path
• A collaborative, fast-paced, data-driven environment where we inspire ourselves and each other to always perform at the top of our game
• Access to learning and development resources to help you get in the best professional shape of your life
• Robust and market-competitive compensation & benefits package (Base, Performance Bonus, Equity, health, welfare & retirement programs)
• Flexible PTO
• Rapid career advancement for strong performers
• Potential ability to work on multiple BridgeBio Pharma programs across multiple therapeutic areas over time 
• Partnerships with leading institutions
• Commitment to Diversity, Equity & Inclusion